McClellan Mark B. 4

What Happened

• Mark B. McClellan, a member of Alignment Healthcare’s Board of Directors, was granted 13,096 restricted stock units (RSUs) on March 13, 2026. The Form 4 reports the acquisition price as $0.00 (transaction code A — award/grant). These RSUs represent rights to receive one share of common stock per unit upon vesting.

Key Details

• Transaction date: 2026-03-13; Report filed: 2026-03-17 (filed within required two business days).
• Award: 13,096 restricted stock units; reported price: $0.00; transaction code: A (award/grant).
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote (F1): The 13,096 RSUs vest on the one-year anniversary of the grant date unless McClellan ceases to serve on the Board before that date (forfeiture condition).
• This is a compensation award to a director — not an open-market purchase or sale.

Context

• RSUs are restricted until they vest and then convert into ordinary shares; they do not represent immediately tradable shares. Director RSU grants are a common part of board compensation and do not, by themselves, indicate an insider buying or selling stock for investment reasons.